摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dicyclohexyl(2-methoxy-6-methylbiphenyl-2,-yl)phosphine | 1351394-95-0

中文名称
——
中文别名
——
英文名称
dicyclohexyl(2-methoxy-6-methylbiphenyl-2,-yl)phosphine
英文别名
dicyclohexyl(2-methoxy-6-methylbiphenyl-2'-yl)phosphane;Dicyclohexyl(2'-methoxy-6'-methyl-[1,1'-biphenyl]-2-yl)phosphine;dicyclohexyl-[2-(2-methoxy-6-methylphenyl)phenyl]phosphane
dicyclohexyl(2-methoxy-6-methylbiphenyl-2<sup>,</sup>-yl)phosphine化学式
CAS
1351394-95-0
化学式
C26H35OP
mdl
——
分子量
394.537
InChiKey
KXOMFFPYBZMOLS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.1
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    联芳取代膦配体的模块化合成:在微波辅助钯催化 CN 交叉偶联反应中的应用
    摘要:
    通过芳基锂与 1,2-二溴苯的无过渡金属“ARYNE”交叉偶联反应和随后通过溴-锂互变进行区域选择性功能化,已经合成了基于联芳基取代的单膦基配体。这些配体用于钯催化的 C-N 键形成反应。发现该反应具有广泛的底物适用性。在微波辐射下,多种伯胺和仲胺与一系列不同取代的卤代苯成功偶联,以良好或优异的产率得到预期产物。
    DOI:
    10.1002/ejoc.201500962
  • 作为试剂:
    描述:
    溴苯正己胺dicyclohexyl(2-methoxy-6-methylbiphenyl-2,-yl)phosphinepotassium tert-butylate 、 palladium diacetate 作用下, 以 1,4-二氧六环 为溶剂, 反应 0.17h, 以76%的产率得到N-N-己基苯胺
    参考文献:
    名称:
    联芳取代膦配体的模块化合成:在微波辅助钯催化 CN 交叉偶联反应中的应用
    摘要:
    通过芳基锂与 1,2-二溴苯的无过渡金属“ARYNE”交叉偶联反应和随后通过溴-锂互变进行区域选择性功能化,已经合成了基于联芳基取代的单膦基配体。这些配体用于钯催化的 C-N 键形成反应。发现该反应具有广泛的底物适用性。在微波辐射下,多种伯胺和仲胺与一系列不同取代的卤代苯成功偶联,以良好或优异的产率得到预期产物。
    DOI:
    10.1002/ejoc.201500962
点击查看最新优质反应信息

文献信息

  • NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE
    申请人:Calvet James P.
    公开号:US20110082098A1
    公开(公告)日:2011-04-07
    Novobiocin analogues are useful in methods of treating, inhibiting, and/or preventing cyst formation in autosomal dominant polycystic kidney disease (ADPKD) in a subject. The disclosure provides methods of treating ADPKD comprising administering a therapeutically effective amount of a coumarin-3-carboxamide novobiocin analogue. Accordingly, the method can include administering a novobiocin analogue in a therapeutically effective amount for reducing levels of mTOR pathway phosphoproteins P-mTOR, P-Akt and P-S6K, or combinations thereof. Further, the method can include administering a novobiocin analogue in a therapeutically effective amount for reducing levels of Hsp-90 client proteins CFTR, ErbB2, c-Raf and Cdk4, or combinations thereof.
    新比奴霉素类似物在治疗、抑制和/或预防自体显性多囊肾病(ADPKD)中的囊肿形成方法中是有用的。本公开提供了治疗ADPKD的方法,包括给予香豆素-3-羧酰胺新比奴霉素类似物的治疗有效量。因此,该方法可以包括给予新比奴霉素类似物的治疗有效量,以降低mTOR途径磷酸化蛋白P-mTOR、P-Akt和P-S6K的水平,或其组合。此外,该方法可以包括给予新比奴霉素类似物的治疗有效量,以降低Hsp-90客体蛋白CFTR、ErbB2、c-Raf和Cdk4的水平,或其组合。
  • Triphenylene-Benzofuran/Benzothiophene/Benzoselenophene Compounds With Substituents Joining To Form Fused Rings
    申请人:Ma Bin
    公开号:US20110266526A1
    公开(公告)日:2011-11-03
    Compounds comprising a triphenylene moiety and a benzo- or dibenzo-moiety are provided. In particular, the benzo- or dibenzo-moiety has a fused substituent. These compounds may be used in organic light emitting devices, particularly in combination with yellow, orange and red emitters, to provide devices with improved properties.
    提供了包含三苯基单元和苯基或二苯基单元的化合物。特别是,苯基或二苯基单元具有融合取代基。这些化合物可以用于有机发光器件,特别是与黄色、橙色和红色发射体结合使用,以提供具有改进性能的器件。
  • PHOSPHORUS-CONTAINING CATALYSTS
    申请人:AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    公开号:US20160207034A1
    公开(公告)日:2016-07-21
    The invention provides compounds of general structure I: (Ar 1 —Ar 2 —Ar 3 -E-P(=D)R 2 -) n M m X n L n ″. In this structure: •Ar 1 , Ar 2 and Ar 3 are aromatic groups wherein: —Ar 1 and Ar 3 are in a 1,3 relationship on Ar 2 , —each of Ar 1 , Ar 2 and Ar 3 optionally comprises one or more ring substituents of formula YR′ r wherein each Y independently is absent or is O, S, B, N or Si and each R′ is independently H, halogen, alkyl, cycloalkyl, aryl or heteroaryl and r is 1, 2 or 3, where r is 1 if Y is absent or is O or S, 2 if Y is B or N and 3 if Y is Si, —Ar 1 , Ar 2 and Ar 3 are each independently carbocyclic or heterocyclic and each is independently monocyclic, bicyclic or polycyclic and each ring of each of Ar 1 , Ar 2 and Ar 3 independently has 5, 6 or 7 ring atoms; •E is absent or is selected from the group consisting of O, S, NR″, SiR″ 2 , AsR″ 2 and CR″ 2 ; •M is a complexing metal; •X is selected from the group consisting of H, F, Br, CI, I, OTf, dba (dibenzylidene acetone), OC(═O)CF 3 and OAc; •L is selected from the group consisting of PR″ 2 , NR″ 2 , OR″, SR″, SiR″ 3 , AsR″ 3 , alkene, alkyne, aryl and heteroaryl, each of said alkene, alkyne, aryl and heteroaryl being optionally substituted, for example with one or more halogens and/or with one or more R groups as defined herein; •each R is independently alkyl, cycloalkyl, heterocyclyl, heterocycloalkyl, aryl or -, heteroaryl; •D is absent or is ═S or —O or —Z-linker-Z—, where each Z independently is O or NH or N-alkyl and linker is an alkyl chain of 2-5 carbon atoms in length; •each R″ is independently H, alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl, each other than H being optionally substituted, or R″ 2 is —Z-linker-Z— as defined above; and •m is 0 or 1 or 2; wherein if m is 0, n is 1, n′ and n″ are 0 and -- is absent; and if m is 1 or 2, n is 1 or 2 and n′ and n″ are integers such that the coordination sphere of M is filled, and D is absent.
    该发明提供了一般结构I的化合物:(Ar1—Ar2—Ar3-E-P(=D)R2-)nMmXnLn″。在这个结构中: •Ar1,Ar2和Ar3是芳香族基团,其中:—Ar1和Ar3在Ar2上呈1,3关系,—Ar1,Ar2和Ar3中的每一个可选地包括一个或多个环取代基,其化学式为YR′r,其中每个Y独立地不存在或为O、S、B、N或Si,每个R′独立地为H、卤素、烷基、环烷基、芳基或杂芳基,r为1、2或3,其中如果Y不存在或为O或S,则r为1,如果Y为B或N,则r为2,如果Y为Si,则r为3,—Ar1,Ar2和Ar3分别独立地为碳环或杂环,每个分别独立地为单环、双环或多环,每个Ar1,Ar2和Ar3的每个环独立地具有5、6或7个环原子; •E不存在或从O、S、NR″、SiR″2、AsR″2和CR″2组成的群体中选择; •M是络合金属; •X从H、F、Br、Cl、I、OTf、dba(双苯亚乙酮)、OC(═O)CF3和OAc组成的群体中选择; •L从PR″2、NR″2、OR″、SR″、SiR″3、AsR″3、烯烃、炔烃、芳基和杂芳基组成的群体中选择,所述的每个烯烃、炔烃、芳基和杂芳基可选地被取代,例如用一个或多个卤素和/或如本文所定义的一个或多个R基取代; •每个R独立地为烷基、环烷基、杂环烷基、杂环烷基、芳基或-、杂芳基; •D不存在或为═S或—O或—Z-连接-Z—,其中每个Z独立地为O或NH或N-烷基,连接体为长度为2-5个碳原子的烷基链; •每个R″独立地为H、烷基、环烷基、杂环烷基、芳基或杂芳基,除H外的每个均可选地被取代,或R″2为—Z-连接-Z—如上所定义;和 •m为0或1或2;其中如果m为0,n为1,n′和n″为0且--不存在;如果m为1或2,n为1或2,n′和n″为整数,使得M的配位球填满,并且D不存在。
  • SECONDARY HOLE TRANSPORTING LAYER WITH DIARYLAMINO-PHENYL-CARBAZOLE COMPOUNDS
    申请人:Kwong Raymond
    公开号:US20130241401A1
    公开(公告)日:2013-09-19
    Novel diarylamino phenyl carbazole compounds are provided. By appropriately selecting the nature of the diarylamino substituent and the substitution on the carbazole nitrogen, compounds with appropriate HOMO and LUMO energies can be obtained for use as materials in a secondary hole transport layer.
    提供了新颖的二芳胺基苯基咔唑化合物。通过适当选择二芳胺基取代基的性质和咔唑氮上的取代基,可以获得适用于作为次级空穴传输层材料的化合物,其具有适当的HOMO和LUMO能量。
  • PHOSPHORESCENT MATERIALS
    申请人:Universal Display Corporation
    公开号:US20150307535A1
    公开(公告)日:2015-10-29
    Novel organic compounds containing a twisted aryl group are provided. In particular, the compounds provided contain a 2-phenylpyridine ligand having a twisted aryl group on the pyridine portion of the ligand. The compounds may be used in organic light emitting devices, particularly as emitting dopants. Devices comprising the compounds containing twisted aryl may demonstrate improved color, efficiency, stability and manufacturing. Additionally, methods are provided for making homoleptic Ir (III) compounds which may contain a twisted aryl.
    提供了含有扭曲芳基团的新型有机化合物。具体来说,所提供的化合物包含在配体的吡啶部分上具有扭曲芳基团的2-苯基吡啶配体。这些化合物可以用于有机发光器件,特别是作为发射掺杂剂。含有扭曲芳基的化合物的器件可能表现出改善的颜色、效率、稳定性和制造工艺。此外,提供了制备可能含有扭曲芳基的同核铱(III)化合物的方法。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐